Literature DB >> 11404369

Role of activin A in negative regulation of normal and tumor B lymphocytes.

D Zipori1, M Barda-Saad.   

Abstract

Activin A, a member of the transforming growth factor beta superfamily, has a wide spread expression pattern and pleiotropic functions. In this overview we summarize data that points to a role of activin A in negative regulation of B lineage lymphocytes. Experiments performed by us and by other groups revealed the capacity of activin A to cause apoptotic death of tumor myeloma cells, through mechanisms of cell cycle inhibition and antagonism with the survival signal of interleukin-6. In vitro studies on B lymphocyte generation from bone marrow stem cells and use of human nasal polyps as a model of inflamed tissue further demonstrate an inhibitory role of activin A in B cell spread and accumulation. These data are analyzed with respect to our model of tissue organization that we term the "restrictin model of cell growth regulation." This model assumes a morphogen-like role of activin A in the hematopoietic system. Thus, the relative concentration of biologically functional activin A, in different parts of the tissue, may determine the local B cell content and functional state of these cells within a specific microenvironment.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11404369

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  14 in total

Review 1.  Immunoregulation by members of the TGFβ superfamily.

Authors:  WanJun Chen; Peter Ten Dijke
Journal:  Nat Rev Immunol       Date:  2016-11-25       Impact factor: 53.106

Review 2.  Early B lymphocyte development: Similarities and differences in human and mouse.

Authors:  Michiko Ichii; Kenji Oritani; Yuzuru Kanakura
Journal:  World J Stem Cells       Date:  2014-09-26       Impact factor: 5.326

3.  In vivo amelioration of endogenous antitumor autoantibodies via low-dose P4N through the LTA4H/activin A/BAFF pathway.

Authors:  Yu-Ling Lin; Nu-Man Tsai; Cheng-Hao Hsieh; Shu-Yi Ho; Jung Chang; Hsin-Yi Wu; Ming-Hua Hsu; Chia-Ching Chang; Kuang-Wen Liao; Tiffany L B Jackson; David E Mold; Ru Chih C Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-17       Impact factor: 11.205

4.  Homeoprotein DLX-1 interacts with Smad4 and blocks a signaling pathway from activin A in hematopoietic cells.

Authors:  Shigeru Chiba; Kenichi Takeshita; Yoichi Imai; Keiki Kumano; Mineo Kurokawa; Shigeo Masuda; Kiyoshi Shimizu; Shuji Nakamura; Frank H Ruddle; Hisamaru Hirai
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-11       Impact factor: 11.205

5.  Inhibitory effects of osteoblasts and increased bone formation on myeloma in novel culture systems and a myelomatous mouse model.

Authors:  Shmuel Yaccoby; Michele J Wezeman; Maurizio Zangari; Ronald Walker; Michele Cottler-Fox; Danna Gaddy; Wen Ling; Rinku Saha; Bart Barlogie; Guido Tricot; Joshua Epstein
Journal:  Haematologica       Date:  2006-02       Impact factor: 9.941

6.  The hemopoietic stem cell niche versus the microenvironment of the multiple myeloma-tumor initiating cell.

Authors:  Dov Zipori
Journal:  Cancer Microenviron       Date:  2010-02-05

7.  Serum activin A and B levels predict outcome in patients with acute respiratory failure: a prospective cohort study.

Authors:  David Morritz de Kretser; Jonathan Guy Bensley; Ville Pettilä; Rita Linko; Mark Peter Hedger; Susan Hayward; Carolyn Anne Allan; Robert Ian McLachlan; Helen Ludlow; David James Phillips
Journal:  Crit Care       Date:  2013-10-31       Impact factor: 9.097

Review 8.  Intertwining of Activin A and TGFβ Signaling: Dual Roles in Cancer Progression and Cancer Cell Invasion.

Authors:  Holli A Loomans; Claudia D Andl
Journal:  Cancers (Basel)       Date:  2014-12-30       Impact factor: 6.639

Review 9.  The immunoregulatory and fibrotic roles of activin A in allergic asthma.

Authors:  C L Hardy; J M Rolland; R E O'Hehir
Journal:  Clin Exp Allergy       Date:  2015-10       Impact factor: 5.018

10.  Substantial Increases Occur in Serum Activins and Follistatin during Lung Transplantation.

Authors:  David M de Kretser; Jonathan G Bensley; David J Phillips; Bronwyn J Levvey; Greg I Snell; Enjarn Lin; Mark P Hedger; Robyn E O'Hehir
Journal:  PLoS One       Date:  2016-01-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.